Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of VAQTA Co-administered with PedvaxHIB and Infanrix
NCT00289913Phase 4Completed
- Sponsor
- Merck & Co.
- Start
- Apr 2006
- Primary completion
- Jun 2010
- Modality
- Whole Inactivated Vaccines
01
Overview
A Phase 4 trial of inactivated hepatitis A virus vaccine in hepatitis A (HAV), sponsored by Merck & Co.. Started Apr 2006; status: completed.
02
Drugs
inactivated hepatitis A virus vaccine
03
Conditions
hepatitis A (HAV)
Beyond the preview
Go deeper on NCT00289913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00289913.